Hoffmann-La Roche

B-59

NCT03281954

JBG-1801

Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

Status:

Recruiting

26459-200.png

III

Phase

Line of Therapy.png

Neoajduvant

Line of Therapy

Disease Stage.png

Disease Stage

Target.png

Biomarker(s)

TNBC

Investigational

Product

Atezolizumab

Treatment Arms

o Placebo

o Atezolizumab